Looks like the G patch is finally getting traction.
There's a great clinical need for products like the G patch. There is no equivalent in the area of remote cardiac monitoring that I'm aware of.
Not only are patients numbers and trend looking good, but the fact that we've got 10 universities, and then another 7 coming on board, in the US, which is a difficult market to break into, is phenomenal. Universities are opinion leaders, so the significance of this for future growth in intake cannot be overstated.
Excellent announcement.
GMV Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held
